The Promise and Peril of Chemical Probe Negative Controls. Read more about The Promise and Peril of Chemical Probe Negative Controls.
Structure and activation mechanism of the human liver-type glutaminase GLS2. Read more about Structure and activation mechanism of the human liver-type glutaminase GLS2.
Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants. Read more about Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants.
Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review. Read more about Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review.
Structural basis for RNA 3'-end recognition by the PIWIL2 PAZ domain. Read more about Structural basis for RNA 3'-end recognition by the PIWIL2 PAZ domain.
Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells. Read more about Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells.
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics. Read more about Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics.
7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-ones Designed by a "Cut and Glue" Strategy Are Dual Aurora A/VEGF-R Kinase Inhibitors. Read more about 7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-ones Designed by a "Cut and Glue" Strategy Are Dual Aurora A/VEGF-R Kinase Inhibitors.
Genotoxicity and Epigenotoxicity of Carbazole-Derived Molecules on MCF-7 Breast Cancer Cells. Read more about Genotoxicity and Epigenotoxicity of Carbazole-Derived Molecules on MCF-7 Breast Cancer Cells.
Structures of chromatin modulators in complex with nucleosome. Read more about Structures of chromatin modulators in complex with nucleosome.
